Torrent Pharmaceuticals Limited
Drug Manufacturers - Specialty & Generic · Healthcare
Analyst
Nomura
Equibles does not estimate personal net worth.
Sayan Mukherjee is recorded as Analyst at Nomura. Sayan Mukherjee has spoken on 3 earnings calls across 3 companies, most recently for Torrent Pharmaceuticals Limited on October 23, 2026. Those appearances were for Torrent Pharmaceuticals Limited, Zydus Lifesciences Limited and Cipla Limited. The companies whose calls Sayan Mukherjee spoke on are classified in the Healthcare sector.
“Can you share how large your ratio is now as part of your domestic business? Because it's been going pretty rapidly since you've acquired India from color, and how should you think about the growth here, given all the initiatives going here at least?”
“On the U.S., you mentioned, you know, currently we have 10% of revenues coming from branded. So that would mean roughly, let's say, $130 million, $35 million, right, of revenues on an annual basis.”
“Can you talk about the, you know, accounting change that you mentioned? How has that impacted your growth rates, if you can quantify for the branded markets, particularly India and South Africa?”
Nomura
Analyst
Transcript header (unverified)
Torrent Pharmaceuticals Limited
Drug Manufacturers - Specialty & Generic · Healthcare
Zydus Lifesciences Limited
Drug Manufacturers - Specialty & Generic · Healthcare
Cipla Limited
Drug Manufacturers - Specialty & Generic · Healthcare
Earnings Call for the Quarter Ended September 30, 2026
Torrent Pharmaceuticals Limited
Earnings Call for the Quarter Ended June 30, 2026
Zydus Lifesciences Limited
Earnings Call
Cipla Limited